FDA
Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets
Composition
- Active ingredients
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG; NEVIRAPINE 200MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021988.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Strides Acrolab
- Status
- Tentative approval
- FDA approval
- 2 Mar 2007
- Application
- NDA021988-001